Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cyclacel Pharmaceuti (NQ: CYCC ) 1.670 -0.040 (-2.34%) Streaming Delayed Price Updated: 3:59 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 28,338 Open 1.710 Bid (Size) 1.550 (1) Ask (Size) 1.700 (4) Prev. Close 1.710 Today's Range 1.610 - 1.750 52wk Range 1.300 - 11.40 Shares Outstanding 1,463,259 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions June 26, 2024 Lengthens Patent Exclusivity of Plogosertib until August 2040 From Cyclacel Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session June 12, 2024 Via Benzinga Performance YTD -36.98% -36.98% 1 Month -4.57% -4.57% 3 Month -4.57% -4.57% 6 Month -23.92% -23.92% 1 Year -84.54% -84.54% More News Read More 12 Health Care Stocks Moving In Thursday's After-Market Session June 06, 2024 Via Benzinga Cyclacel’s Fadraciclib Demonstrates Efficacy in Patient-Derived Colorectal Cancer Models at the 2024 ASCO Annual Meeting June 04, 2024 From Cyclacel Via GlobeNewswire Cyclacel Pharmaceuticals Reports New Clinical Data at 2024 ASCO Annual Meeting Highlighting Oral Fadraciclib’s Potential as a Precision Medicine for Cancer June 03, 2024 From Cyclacel Via GlobeNewswire 12 Health Care Stocks Moving In Friday's After-Market Session May 24, 2024 Via Benzinga CYCC Stock Earnings: Cyclacel Pharmaceuticals Beats EPS for Q1 2024 May 14, 2024 Via InvestorPlace Cyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Update May 14, 2024 From Cyclacel Via GlobeNewswire Why Akoustis Technologies Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 13, 2024 Via Benzinga Why JanOne Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket May 13, 2024 Via Benzinga Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results May 08, 2024 From Cyclacel Via GlobeNewswire Cyclacel Pharmaceuticals Announces Closing of $8.0 Million Private Placement Priced At-The-Market Under NASDAQ Rules May 02, 2024 From Cyclacel Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session May 01, 2024 Via Benzinga Why Pinterest Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket May 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 01, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session April 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session April 30, 2024 Via Benzinga Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session April 30, 2024 Via Benzinga Why Is Coursera (COUR) Stock Down 16% Today? April 30, 2024 Via InvestorPlace Why Is Medifast (MED) Stock Down 20% Today? April 30, 2024 Via InvestorPlace Why GeneDx Shares Are Trading Higher By 37%; Here Are 20 Stocks Moving Premarket April 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 30, 2024 Via Benzinga Why Is Greenwave Technology Solutions (GWAV) Stock Up 15% Today? April 30, 2024 Via InvestorPlace Why Is Cyclacel Pharmaceuticals (CYCC) Stock Up 46% Today? April 30, 2024 Via InvestorPlace Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday April 30, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
